Fibrinolysis syndrome
Fibrinolysis Syndrome
Fibrinolysis Syndrome (pronounced: fi-brin-o-ly-sis syn-drome) is a medical condition characterized by an increased rate of fibrinolysis, the process by which the body breaks down blood clots.
Etymology
The term "Fibrinolysis Syndrome" is derived from the words "fibrinolysis" and "syndrome". "Fibrinolysis" comes from the Greek words "fibrin", a protein involved in blood clotting, and "lysis", meaning to break down or dissolve. "Syndrome" is derived from the Greek word "syndromē", meaning "concurrence".
Definition
Fibrinolysis Syndrome is a disorder of the coagulation system, where the body's mechanism for breaking down blood clots, known as fibrinolysis, is overly active. This can lead to excessive bleeding, as clots that are necessary to stop bleeding are broken down too quickly.
Symptoms
Symptoms of Fibrinolysis Syndrome may include hemorrhage, bruising, and prolonged bleeding from wounds or surgical incisions. In severe cases, it can lead to life-threatening bleeding.
Causes
Fibrinolysis Syndrome can be caused by a variety of factors, including certain medications, liver disease, and certain types of cancer. It can also be a complication of major surgery or trauma.
Treatment
Treatment for Fibrinolysis Syndrome typically involves addressing the underlying cause of the condition. This may include discontinuing certain medications, treating underlying diseases, or administering medications to slow the rate of fibrinolysis.
Related Terms
External links
- Medical encyclopedia article on Fibrinolysis syndrome
- Wikipedia's article - Fibrinolysis syndrome
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski